Ang II and baroreflex function in rabbits with CHF and lesions of the area postrema

Jun Li Liu, Hiroshi Murakami, Max Sanderford, Vernon S. Bishop, Irving H Zucker

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Blockade of the angiotensin II (ANG II) type 1 receptor (AT1) has been shown to restore baroreflex sensitivity in rats and rabbits with experimental chronic heart failure (CHF). Because the modulation of baroreflex function in response to ANG II is mediated in part by AT1 receptors located in the area postrema, we hypothesized that lesions of the area postrema would prevent the enhancement in baroreflex function in response to AT1-receptor blockade in rabbits with pacing-induced CHF. Experiments were carried out on 24 male New Zealand White rabbits that were divided into sham (n = 12) and lesioned (n = 12) groups further divided into normal and CHF subgroups (n = 6 each). All rabbits were identically instrumented to measure cardiac external dimensions, central venous pressure, arterial pressure, heart rate (HR), and renal sympathetic nerve activity (RSNA). After 3-4 wk of pacing, baroreflex sensitivity (infusions of phenylephrine and nitroprusside) was evaluated before and after intravenous administration of the AT1-receptor antagonist L-158,809. Maximum baroreflex sensitivity in nonpaced rabbits was 5.4 ± 0.7 beats · min-1 · mmHg-1 and 5.2 ± 0.5% of maximum/mmHg for HR and RSNA curves, respectively, and was not altered by L-158,809 in either intact or lesioned rabbits. In contrast, L-158,809 enhanced baroreflex sensitivity in intact rabbits with CHF (HR from 1.6 ± 0.3 to 4.1 ± 0.7 beats · min-1 · mmHg-1, P < 0.001; RSNA from 2.3 ± 0.2 to 4.9 ± 0.4% of maximum/mmHg, P < 0.001). However, in CHF rabbits with area postrema lesions, L-158,809 failed to enhance baroreflex sensitivity. Interestingly, area postrema lesions did not normalize the baroreflex in CHF rabbits. From these data we conclude that the area postrema mediates the normalization of baroreflex sensitivity after AT1 blockade in rabbits with CHF but does not modify resting baroreflex function.

Original languageEnglish (US)
Pages (from-to)H342-H350
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume277
Issue number1 46-1
StatePublished - Jul 1 1999

Fingerprint

Area Postrema
Baroreflex
Heart Failure
Rabbits
Heart Rate
Kidney
Angiotensin Type 1 Receptor
Central Venous Pressure
Nitroprusside
Phenylephrine
Angiotensin II
Intravenous Administration
Arterial Pressure

Keywords

  • Angiotensin II
  • Angiotensin receptors
  • Central nervous system
  • Experimental heart failure
  • Sympathetic nerve activity

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Ang II and baroreflex function in rabbits with CHF and lesions of the area postrema. / Liu, Jun Li; Murakami, Hiroshi; Sanderford, Max; Bishop, Vernon S.; Zucker, Irving H.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 277, No. 1 46-1, 01.07.1999, p. H342-H350.

Research output: Contribution to journalArticle

Liu, Jun Li ; Murakami, Hiroshi ; Sanderford, Max ; Bishop, Vernon S. ; Zucker, Irving H. / Ang II and baroreflex function in rabbits with CHF and lesions of the area postrema. In: American Journal of Physiology - Heart and Circulatory Physiology. 1999 ; Vol. 277, No. 1 46-1. pp. H342-H350.
@article{ba7d0712eb43407dbe95efc207a6dd24,
title = "Ang II and baroreflex function in rabbits with CHF and lesions of the area postrema",
abstract = "Blockade of the angiotensin II (ANG II) type 1 receptor (AT1) has been shown to restore baroreflex sensitivity in rats and rabbits with experimental chronic heart failure (CHF). Because the modulation of baroreflex function in response to ANG II is mediated in part by AT1 receptors located in the area postrema, we hypothesized that lesions of the area postrema would prevent the enhancement in baroreflex function in response to AT1-receptor blockade in rabbits with pacing-induced CHF. Experiments were carried out on 24 male New Zealand White rabbits that were divided into sham (n = 12) and lesioned (n = 12) groups further divided into normal and CHF subgroups (n = 6 each). All rabbits were identically instrumented to measure cardiac external dimensions, central venous pressure, arterial pressure, heart rate (HR), and renal sympathetic nerve activity (RSNA). After 3-4 wk of pacing, baroreflex sensitivity (infusions of phenylephrine and nitroprusside) was evaluated before and after intravenous administration of the AT1-receptor antagonist L-158,809. Maximum baroreflex sensitivity in nonpaced rabbits was 5.4 ± 0.7 beats · min-1 · mmHg-1 and 5.2 ± 0.5{\%} of maximum/mmHg for HR and RSNA curves, respectively, and was not altered by L-158,809 in either intact or lesioned rabbits. In contrast, L-158,809 enhanced baroreflex sensitivity in intact rabbits with CHF (HR from 1.6 ± 0.3 to 4.1 ± 0.7 beats · min-1 · mmHg-1, P < 0.001; RSNA from 2.3 ± 0.2 to 4.9 ± 0.4{\%} of maximum/mmHg, P < 0.001). However, in CHF rabbits with area postrema lesions, L-158,809 failed to enhance baroreflex sensitivity. Interestingly, area postrema lesions did not normalize the baroreflex in CHF rabbits. From these data we conclude that the area postrema mediates the normalization of baroreflex sensitivity after AT1 blockade in rabbits with CHF but does not modify resting baroreflex function.",
keywords = "Angiotensin II, Angiotensin receptors, Central nervous system, Experimental heart failure, Sympathetic nerve activity",
author = "Liu, {Jun Li} and Hiroshi Murakami and Max Sanderford and Bishop, {Vernon S.} and Zucker, {Irving H}",
year = "1999",
month = "7",
day = "1",
language = "English (US)",
volume = "277",
pages = "H342--H350",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "1 46-1",

}

TY - JOUR

T1 - Ang II and baroreflex function in rabbits with CHF and lesions of the area postrema

AU - Liu, Jun Li

AU - Murakami, Hiroshi

AU - Sanderford, Max

AU - Bishop, Vernon S.

AU - Zucker, Irving H

PY - 1999/7/1

Y1 - 1999/7/1

N2 - Blockade of the angiotensin II (ANG II) type 1 receptor (AT1) has been shown to restore baroreflex sensitivity in rats and rabbits with experimental chronic heart failure (CHF). Because the modulation of baroreflex function in response to ANG II is mediated in part by AT1 receptors located in the area postrema, we hypothesized that lesions of the area postrema would prevent the enhancement in baroreflex function in response to AT1-receptor blockade in rabbits with pacing-induced CHF. Experiments were carried out on 24 male New Zealand White rabbits that were divided into sham (n = 12) and lesioned (n = 12) groups further divided into normal and CHF subgroups (n = 6 each). All rabbits were identically instrumented to measure cardiac external dimensions, central venous pressure, arterial pressure, heart rate (HR), and renal sympathetic nerve activity (RSNA). After 3-4 wk of pacing, baroreflex sensitivity (infusions of phenylephrine and nitroprusside) was evaluated before and after intravenous administration of the AT1-receptor antagonist L-158,809. Maximum baroreflex sensitivity in nonpaced rabbits was 5.4 ± 0.7 beats · min-1 · mmHg-1 and 5.2 ± 0.5% of maximum/mmHg for HR and RSNA curves, respectively, and was not altered by L-158,809 in either intact or lesioned rabbits. In contrast, L-158,809 enhanced baroreflex sensitivity in intact rabbits with CHF (HR from 1.6 ± 0.3 to 4.1 ± 0.7 beats · min-1 · mmHg-1, P < 0.001; RSNA from 2.3 ± 0.2 to 4.9 ± 0.4% of maximum/mmHg, P < 0.001). However, in CHF rabbits with area postrema lesions, L-158,809 failed to enhance baroreflex sensitivity. Interestingly, area postrema lesions did not normalize the baroreflex in CHF rabbits. From these data we conclude that the area postrema mediates the normalization of baroreflex sensitivity after AT1 blockade in rabbits with CHF but does not modify resting baroreflex function.

AB - Blockade of the angiotensin II (ANG II) type 1 receptor (AT1) has been shown to restore baroreflex sensitivity in rats and rabbits with experimental chronic heart failure (CHF). Because the modulation of baroreflex function in response to ANG II is mediated in part by AT1 receptors located in the area postrema, we hypothesized that lesions of the area postrema would prevent the enhancement in baroreflex function in response to AT1-receptor blockade in rabbits with pacing-induced CHF. Experiments were carried out on 24 male New Zealand White rabbits that were divided into sham (n = 12) and lesioned (n = 12) groups further divided into normal and CHF subgroups (n = 6 each). All rabbits were identically instrumented to measure cardiac external dimensions, central venous pressure, arterial pressure, heart rate (HR), and renal sympathetic nerve activity (RSNA). After 3-4 wk of pacing, baroreflex sensitivity (infusions of phenylephrine and nitroprusside) was evaluated before and after intravenous administration of the AT1-receptor antagonist L-158,809. Maximum baroreflex sensitivity in nonpaced rabbits was 5.4 ± 0.7 beats · min-1 · mmHg-1 and 5.2 ± 0.5% of maximum/mmHg for HR and RSNA curves, respectively, and was not altered by L-158,809 in either intact or lesioned rabbits. In contrast, L-158,809 enhanced baroreflex sensitivity in intact rabbits with CHF (HR from 1.6 ± 0.3 to 4.1 ± 0.7 beats · min-1 · mmHg-1, P < 0.001; RSNA from 2.3 ± 0.2 to 4.9 ± 0.4% of maximum/mmHg, P < 0.001). However, in CHF rabbits with area postrema lesions, L-158,809 failed to enhance baroreflex sensitivity. Interestingly, area postrema lesions did not normalize the baroreflex in CHF rabbits. From these data we conclude that the area postrema mediates the normalization of baroreflex sensitivity after AT1 blockade in rabbits with CHF but does not modify resting baroreflex function.

KW - Angiotensin II

KW - Angiotensin receptors

KW - Central nervous system

KW - Experimental heart failure

KW - Sympathetic nerve activity

UR - http://www.scopus.com/inward/record.url?scp=0032818579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032818579&partnerID=8YFLogxK

M3 - Article

C2 - 10409214

AN - SCOPUS:0032818579

VL - 277

SP - H342-H350

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 1 46-1

ER -